Pet Cardiology Market
PUBLISHED: 2026 ID: SMRC40475
SHARE
SHARE

Pet Cardiology Market

Pet Cardiology Market Forecasts to 2034 - Global Analysis By Disease Type (Congestive Heart Failure, Cardiomyopathy, Valvular Heart Disease, Arrhythmias and Other Cardiac Disorders), Service / Product Type, Pet Type, End User, and By Geography

4.3 (87 reviews)
4.3 (87 reviews)
Published: 2026 ID: SMRC40475

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...
According to Stratistics MRC, the Global Pet Cardiology Market is accounted for $1.6 billion in 2026 and is expected to reach $2.9 billion by 2034 growing at a CAGR of 7.7% during the forecast period. Pet cardiology focuses on the diagnosis, monitoring, and treatment of cardiovascular diseases in companion animals, particularly dogs and cats. The market encompasses congestive heart failure, cardiomyopathy, valvular heart disease, arrhythmias, and other cardiac disorders. Key services and products include diagnostic testing and imaging, pharmaceuticals, cardiac monitoring devices, and interventional and surgical procedures. Growing awareness of companion animal health, increasing demand for advanced veterinary diagnostics, improvements in cardiac imaging, and the expansion of specialized veterinary services are supporting market development. Veterinary hospitals, specialty cardiology clinics, and general veterinary clinics represent the principal end users.

Market Dynamics:

Driver:

Increasing prevalence of companion animal cardiac disorders and demand for early diagnosis

Growing recognition of cardiovascular diseases in companion animals is supporting demand for specialized veterinary cardiology services. Dogs and cats can develop conditions such as degenerative mitral valve disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, and cardiac arrhythmias, creating demand for timely diagnosis and ongoing treatment. Advancements in echocardiography, electrocardiography, cardiac biomarker testing, and diagnostic imaging are helping veterinarians identify abnormalities and assess disease progression. Increasing pet ownership and greater willingness among owners to invest in advanced veterinary care are further supporting demand. As veterinary practitioners emphasize early detection, disease monitoring, and individualized treatment, the need for specialized cardiology products and services is expected to increase.

Restraint:

High diagnostic and treatment costs and limited access to veterinary cardiologists

The high cost of advanced cardiac diagnostics and treatment can restrict access to veterinary cardiology services. Echocardiography, specialized imaging, cardiac biomarker testing, long-term medication, and interventional procedures may require substantial expenditure, particularly for animals with chronic conditions requiring continued monitoring. Access can also be limited by the uneven distribution of veterinary cardiologists and specialized hospitals, especially in smaller cities and developing markets. Referral appointments, travel requirements, and the need for repeated assessments may create additional burdens for pet owners. These financial and accessibility challenges can delay specialist consultations, limit the use of advanced diagnostic procedures, and encourage reliance on general veterinary services.

Opportunity:

Advancements in cardiac diagnostics, AI-assisted imaging, and remote monitoring

Technological innovation is creating opportunities for improved cardiovascular assessment and management in companion animals. Advanced echocardiography, portable ultrasound systems, electrocardiography, and cardiac biomarker tests can support earlier identification and evaluation of heart disease. Artificial intelligence and automated image analysis may help streamline measurements and improve diagnostic workflows when used with appropriate clinical interpretation. Telecardiology and remote consultation services can connect general veterinary practitioners with specialists, improving access to expert assessment in underserved locations. In addition, developments in wearable monitoring and connected diagnostic technologies may support longitudinal observation of selected cardiac parameters. These innovations create opportunities for diagnostic equipment manufacturers, veterinary laboratories, pharmaceutical companies, and specialized service providers.

Threat:

Shortage of specialized veterinary professionals and variability in diagnostic capabilities

The pet cardiology market faces challenges arising from shortages of trained veterinary cardiologists, differences in diagnostic capabilities, and inconsistent access to specialized equipment. Advanced cardiac assessment requires appropriate clinical expertise, imaging interpretation, and the ability to distinguish cardiac disease from other conditions with similar symptoms. Limited availability of specialist services can create referral delays and restrict treatment options. Furthermore, variations in equipment quality, diagnostic protocols, and practitioner training may affect the consistency of clinical assessments. Economic uncertainty and pressure on household spending can also lead owners to postpone elective investigations or expensive treatment plans. Addressing workforce limitations, improving training, and expanding access to reliable diagnostic tools will remain important for market development.

Covid-19 Impact:

The COVID-19 pandemic disrupted veterinary healthcare delivery through temporary clinic restrictions, reduced routine appointments, staffing limitations, and supply chain interruptions. Some non-emergency cardiac assessments and specialist consultations were postponed, affecting the timing of diagnosis and treatment for companion animals. At the same time, veterinary practices adopted appointment-based services, teleconsultations, and alternative approaches to maintaining continuity of care. Following the pandemic, the resumption of veterinary visits and continued attention to companion animal health have supported demand for diagnostic testing, imaging, and treatment services. Greater use of digital veterinary platforms and remote specialist consultations has also created opportunities to improve access to cardiology expertise, particularly where specialist services are geographically limited.

The Diagnostics and Imaging segment is expected to be the largest during the forecast period

The Diagnostics and Imaging segment is expected to account for the largest share of the Global Pet Cardiology Market, supported by the essential role of diagnostic assessment in identifying and managing cardiovascular disorders. Echocardiography, electrocardiography, thoracic imaging, and cardiac biomarker testing help veterinarians evaluate cardiac structure, rhythm abnormalities, and indicators of heart disease. These procedures support initial diagnosis, assessment of disease severity, treatment planning, and ongoing monitoring. Veterinary hospitals and specialty cardiology clinics increasingly rely on advanced diagnostic equipment and laboratory services to manage complex cardiac cases. Continued improvements in imaging quality, portability, and automated analysis are expected to strengthen demand for diagnostic and imaging solutions.

The Cardiac Monitoring Devices segment is expected to witness strong growth during the forecast period

The Cardiac Monitoring Devices segment is expected to experience strong growth as veterinary practitioners increasingly emphasize rhythm assessment and continuous or repeated monitoring of animals with suspected or diagnosed cardiac disorders. Electrocardiography systems, ambulatory monitoring technologies, and connected diagnostic platforms can help identify intermittent arrhythmias and evaluate cardiac electrical activity over time. Improvements in portable equipment, digital data transmission, and remote interpretation services are supporting more flexible monitoring approaches. These technologies are particularly relevant for patients requiring follow-up assessments or investigation of symptoms that may not occur during a routine clinic visit. Increasing awareness of arrhythmia detection and improvements in veterinary diagnostic workflows are expected to support segment expansion.

Region with largest share:

During the forecast period, North America is expected to hold the largest share of the Global Pet Cardiology Market, supported by established veterinary healthcare infrastructure, access to advanced diagnostic equipment, and a well-developed network of veterinary hospitals and specialist clinics. The United States represents a major market for veterinary diagnostics, cardiac pharmaceuticals, and specialized companion animal care. Availability of veterinary cardiologists, established laboratory networks, and access to echocardiography and electrocardiography services support the diagnosis and management of cardiovascular conditions. In addition, pet owners' willingness to invest in advanced veterinary treatment and the presence of leading animal health and diagnostic companies contribute to regional market development.

Region with highest CAGR:

Asia Pacific is expected to witness the highest CAGR during the forecast period, driven by growing companion animal healthcare expenditure, expanding veterinary infrastructure, and increasing awareness of advanced diagnostic services. China, Japan, India, South Korea, and Australia represent important markets with developing opportunities for veterinary imaging, cardiac pharmaceuticals, and specialist consultations. Urbanization and the expansion of organized veterinary hospital networks are improving access to diagnostic services, while rising demand for professional pet healthcare is encouraging investment in modern clinical equipment. The growing availability of portable diagnostic technologies and digital veterinary consultations may further support access to cardiology services beyond major metropolitan centers.

Key players in the market

Some of the key players in the Global Pet Cardiology Market include Boehringer Ingelheim, Elanco Animal Health Incorporated, Dechra Pharmaceuticals PLC, Ceva Santé Animale, IDEXX Laboratories, Inc., Antech Diagnostics, Inc., Heska Corporation, GE HealthCare, FUJIFILM Holdings Corporation, and Esaote S.p.A.

Key Developments:

In August 2026, IDEXX Laboratories, Inc. announced the launch of the Catalyst proBNP Test, a dual-species, in-clinic cardiac biomarker test for cats and dogs. The test expands the company's point-of-care diagnostic portfolio by enabling quantitative assessment of NT-proBNP, supporting the evaluation of heart disease and helping veterinarians make timely clinical decisions.

In April 2026, Boehringer Ingelheim and Eko Health introduced Eko Vet+ CANINEBEAT AI, a canine-specific artificial intelligence solution designed to detect, visualize, and grade heart murmurs. The technology supports earlier identification of potential structural heart disease and can help veterinarians determine when further cardiac evaluation is appropriate.

In April 2026, the U.S. Food and Drug Administration approved Amodip, an amlodipine besylate chewable tablet sponsored by Ceva Santé Animale, for controlling systemic hypertension in cats. The approval expands veterinary treatment options for feline hypertension, a condition that can damage the heart and other organs when left uncontrolled.

In May 2025, Esaote S.p.A. presented its MyLab Heron veterinary ultrasound system at the SCIVAC Rimini Congress in Italy. The portable ultrasound platform expands diagnostic imaging options for veterinary practitioners and supports the broader use of ultrasound technology in animal healthcare, including clinical assessments relevant to cardiovascular diagnostics.

Disease Types Covered:
• Congestive Heart Failure
• Cardiomyopathy
• Valvular Heart Disease
• Arrhythmias and Other Cardiac Disorders

Service / Product Types Covered:
• Diagnostics and Imaging
• Pharmaceuticals
• Cardiac Monitoring Devices
• Interventional and Surgical Procedures

Pet Types Covered:
• Dogs
• Cats
• Other Companion Animals

End Users Covered:
• Veterinary Hospitals
• Specialty Cardiology Clinics
• General Veterinary Clinics

Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa

What our report offers:
• Market share assessments for regional and country-level segments
• Strategic recommendations for new entrants
• Covers market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032, and 2034
• Market trends, including drivers, constraints, opportunities, threats, challenges, investment opportunities, and recommendations
• Strategic recommendations for key business segments based on market estimations
• Competitive landscape mapping and assessment of key industry trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends and assessment of the latest technological advancements

Free Customization Offerings:
All customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, forecasts, and CAGR of any prominent country as per the client's interest (subject to feasibility assessment)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Pet Cardiology Market, By Disease Type
5.1 Congestive Heart Failure
5.2 Cardiomyopathy
5.3 Valvular Heart Disease
5.4 Arrhythmias and Other Cardiac Disorders

6 Global Pet Cardiology Market, By Service / Product Type
6.1 Diagnostics and Imaging
6.2 Pharmaceuticals
6.3 Cardiac Monitoring Devices
6.4 Interventional and Surgical Procedures

7 Global Pet Cardiology Market, By Pet Type
7.1 Dogs
7.2 Cats
7.3 Other Companion Animals

8 Global Pet Cardiology Market, By End User
8.1 Veterinary Hospitals
8.2 Specialty Cardiology Clinics
8.3 General Veterinary Clinics

9 Global Pet Cardiology Market, By Geography
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa

10 Strategic Market Intelligence
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives

12 Company Profiles
12.1 Boehringer Ingelheim
12.2 Elanco Animal Health Incorporated
12.3 Dechra Pharmaceuticals PLC
12.4 Ceva Santé Animale
12.5 IDEXX Laboratories, Inc.
12.6 Antech Diagnostics, Inc.
12.7 Heska Corporation
12.8 GE HealthCare
12.9 FUJIFILM Holdings Corporation
12.10 Esaote S.p.A.

List of Tables
1 Global Pet Cardiology Market Outlook, By Region (2023–2034) ($MN)
2 Global Pet Cardiology Market Outlook, By Disease Type (2023–2034) ($MN)
3 Global Pet Cardiology Market Outlook, By Congestive Heart Failure (2023–2034) ($MN)
4 Global Pet Cardiology Market Outlook, By Cardiomyopathy (2023–2034) ($MN)
5 Global Pet Cardiology Market Outlook, By Valvular Heart Disease (2023–2034) ($MN)
6 Global Pet Cardiology Market Outlook, By Arrhythmias and Other Cardiac Disorders (2023–2034) ($MN)
7 Global Pet Cardiology Market Outlook, By Service / Product Type (2023–2034) ($MN)
8 Global Pet Cardiology Market Outlook, By Diagnostics and Imaging (2023–2034) ($MN)
9 Global Pet Cardiology Market Outlook, By Pharmaceuticals (2023–2034) ($MN)
10 Global Pet Cardiology Market Outlook, By Cardiac Monitoring Devices (2023–2034) ($MN)
11 Global Pet Cardiology Market Outlook, By Interventional and Surgical Procedures (2023–2034) ($MN)
12 Global Pet Cardiology Market Outlook, By Pet Type (2023–2034) ($MN)
13 Global Pet Cardiology Market Outlook, By Dogs (2023–2034) ($MN)
14 Global Pet Cardiology Market Outlook, By Cats (2023–2034) ($MN)
15 Global Pet Cardiology Market Outlook, By Other Companion Animals (2023–2034) ($MN)
16 Global Pet Cardiology Market Outlook, By End User (2023–2034) ($MN)
17 Global Pet Cardiology Market Outlook, By Veterinary Hospitals (2023–2034) ($MN)
18 Global Pet Cardiology Market Outlook, By Specialty Cardiology Clinics (2023–2034) ($MN)
19 Global Pet Cardiology Market Outlook, By General Veterinary Clinics (2023–2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials